NCT05879068 - A Study of PM8002 in Combination With Chemotherapy in Patients With SCLC | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 27, 2022

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2026

Conditions

SCLC

Interventions

DRUG

PM8002

IV infusion

DRUG

Paclitaxel

IV infusion

Trial Locations (11)

Peking University Cancer Hospital, Beijing

Jilin Provincial Tumor Hospital, Changchun

Hunan Cancer Hospital, Changsha

Sichuan Provincial People's Hospital, Chengdu

Zhejiang Provincial People's Hospital, Hangzhou

Harbin Medical University Cancer Hospital, Harbin

Shandong Cancer Hospital, Jinan

The First Affiliated Hospital of Nanchang University, Nanchang

Shanghai Pulmonary Hospital, Shanghai

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

Henan Cancer Hospital, Zhengzhou